In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice

Tyrosine kinase inhibitors are validated therapeutic agents against EGFR-mutated non-small cell lung cancer (NSCLC). However, the associated critical side effects of these agents are inevitable, demanding more specific and efficient targeting agents. Recently, we have developed and reported a non-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Zahid Rafiq, Kumar, Manvendra, Sharma, Nisha, Yadav, Umesh Prasad, Singh, Tashvinder, Joshi, Gaurav, Pujala, Brahmam, Raja, Mohd, Chatterjee, Joydeep, Tikoo, Kulbhushan, Singh, Sandeep, Kumar, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457798/
https://www.ncbi.nlm.nih.gov/pubmed/36080307
http://dx.doi.org/10.3390/molecules27175540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457798/
https://www.ncbi.nlm.nih.gov/pubmed/36080307
http://dx.doi.org/10.3390/molecules27175540

Ejemplares similares